UNICHEM LABORATORIES
|
UNICHEM LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity - Authorised | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr |
Equity - Issued | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Paid Up | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹3.06 Cr | ₹12 Cr | ₹11 Cr | ₹7.75 Cr | ₹4.83 Cr |
Total Reserves | ₹2,345 Cr | ₹2,409 Cr | ₹2,594 Cr | ₹2,535 Cr | ₹2,512 Cr |
Securities Premium | ₹1.33 Cr | ₹1.33 Cr | ₹1.33 Cr | ₹1.33 Cr | ₹1.33 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹2,339 Cr | ₹2,398 Cr | ₹2,506 Cr | ₹2,501 Cr | ₹2,495 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹4.87 Cr | ₹10 Cr | ₹86 Cr | ₹32 Cr | ₹16 Cr |
Reserve excluding Revaluation Reserve | ₹2,345 Cr | ₹2,409 Cr | ₹2,594 Cr | ₹2,535 Cr | ₹2,512 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,362 Cr | ₹2,435 Cr | ₹2,618 Cr | ₹2,557 Cr | ₹2,531 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹38 Cr | ₹64 Cr | ₹89 Cr | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹38 Cr | ₹64 Cr | ₹89 Cr | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-6.78 Cr | ₹-10 Cr | ₹-4.36 Cr | ₹-0.25 Cr | ₹-2.94 Cr |
Deferred Tax Assets | ₹96 Cr | ₹82 Cr | ₹94 Cr | ₹77 Cr | ₹94 Cr |
Deferred Tax Liability | ₹89 Cr | ₹72 Cr | ₹90 Cr | ₹77 Cr | ₹91 Cr |
Other Long Term Liabilities | ₹25 Cr | ₹13 Cr | ₹19 Cr | ₹19 Cr | ₹23 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹36 Cr | ₹42 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr |
Total Non-Current Liabilities | ₹92 Cr | ₹108 Cr | ₹144 Cr | ₹49 Cr | ₹44 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹299 Cr | ₹291 Cr | ₹183 Cr | ₹210 Cr | ₹250 Cr |
Sundry Creditors | ₹299 Cr | ₹291 Cr | ₹183 Cr | ₹210 Cr | ₹250 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹115 Cr | ₹128 Cr | ₹135 Cr | ₹177 Cr | ₹122 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹7.69 Cr | ₹25 Cr | ₹27 Cr | ₹28 Cr | ₹10 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹107 Cr | ₹104 Cr | ₹108 Cr | ₹149 Cr | ₹112 Cr |
Short Term Borrowings | ₹155 Cr | ₹208 Cr | ₹216 Cr | ₹101 Cr | ₹184 Cr |
Secured ST Loans repayable on Demands | ₹155 Cr | ₹208 Cr | ₹216 Cr | ₹101 Cr | ₹184 Cr |
Working Capital Loans- Sec | ₹155 Cr | ₹208 Cr | ₹216 Cr | ₹101 Cr | ₹184 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-155 Cr | ₹-208 Cr | ₹-216 Cr | ₹-101 Cr | ₹-184 Cr |
Short Term Provisions | ₹138 Cr | ₹12 Cr | ₹18 Cr | ₹18 Cr | ₹10 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹2.21 Cr | ₹0.49 Cr | ₹2.10 Cr | ₹3.26 Cr | ₹0.63 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹136 Cr | ₹12 Cr | ₹16 Cr | ₹15 Cr | ₹9.81 Cr |
Total Current Liabilities | ₹708 Cr | ₹640 Cr | ₹552 Cr | ₹506 Cr | ₹567 Cr |
Total Liabilities | ₹3,163 Cr | ₹3,183 Cr | ₹3,314 Cr | ₹3,112 Cr | ₹3,142 Cr |
ASSETS | |||||
Gross Block | ₹1,793 Cr | ₹1,750 Cr | ₹1,380 Cr | ₹1,194 Cr | ₹1,098 Cr |
Less: Accumulated Depreciation | ₹597 Cr | ₹494 Cr | ₹390 Cr | ₹313 Cr | ₹232 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,196 Cr | ₹1,257 Cr | ₹990 Cr | ₹880 Cr | ₹866 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹123 Cr | ₹147 Cr | ₹494 Cr | ₹567 Cr | ₹330 Cr |
Non Current Investments | ₹0.02 Cr | ₹0.16 Cr | ₹0.29 Cr | ₹156 Cr | ₹131 Cr |
Long Term Investment | ₹0.02 Cr | ₹0.16 Cr | ₹0.29 Cr | ₹156 Cr | ₹131 Cr |
Quoted | - | ₹0.14 Cr | ₹0.27 Cr | ₹0.15 Cr | ₹0.04 Cr |
Unquoted | ₹4.89 Cr | ₹4.89 Cr | ₹4.89 Cr | ₹155 Cr | ₹131 Cr |
Long Term Loans & Advances | ₹125 Cr | ₹168 Cr | ₹166 Cr | ₹113 Cr | ₹113 Cr |
Other Non Current Assets | ₹21 Cr | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹12 Cr |
Total Non-Current Assets | ₹1,465 Cr | ₹1,591 Cr | ₹1,666 Cr | ₹1,734 Cr | ₹1,455 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹1.34 Cr | ₹1.54 Cr | ₹264 Cr | ₹236 Cr | ₹419 Cr |
Quoted | ₹1.34 Cr | ₹1.25 Cr | ₹38 Cr | ₹236 Cr | ₹419 Cr |
Unquoted | - | ₹0.29 Cr | ₹226 Cr | - | - |
Inventories | ₹705 Cr | ₹625 Cr | ₹600 Cr | ₹538 Cr | ₹397 Cr |
Raw Materials | ₹262 Cr | ₹254 Cr | ₹234 Cr | ₹213 Cr | ₹167 Cr |
Work-in Progress | ₹103 Cr | ₹81 Cr | ₹102 Cr | ₹77 Cr | ₹74 Cr |
Finished Goods | ₹282 Cr | ₹220 Cr | ₹222 Cr | ₹201 Cr | ₹115 Cr |
Packing Materials | ₹33 Cr | ₹25 Cr | ₹22 Cr | ₹24 Cr | ₹22 Cr |
Stores  and Spare | ₹16 Cr | ₹14 Cr | ₹13 Cr | ₹8.97 Cr | ₹5.51 Cr |
Other Inventory | ₹9.80 Cr | ₹31 Cr | ₹8.19 Cr | ₹15 Cr | ₹13 Cr |
Sundry Debtors | ₹610 Cr | ₹589 Cr | ₹495 Cr | ₹250 Cr | ₹390 Cr |
Debtors more than Six months | ₹45 Cr | ₹3.09 Cr | ₹2.27 Cr | ₹5.54 Cr | - |
Debtors Others | ₹569 Cr | ₹588 Cr | ₹496 Cr | ₹250 Cr | ₹394 Cr |
Cash and Bank | ₹154 Cr | ₹185 Cr | ₹114 Cr | ₹82 Cr | ₹234 Cr |
Cash in hand | ₹0.05 Cr | ₹0.05 Cr | ₹0.08 Cr | ₹0.07 Cr | ₹0.07 Cr |
Balances at Bank | ₹154 Cr | ₹185 Cr | ₹114 Cr | ₹82 Cr | ₹234 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹29 Cr | ₹31 Cr | ₹33 Cr | ₹56 Cr | ₹58 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | ₹0.23 Cr | ₹0.12 Cr | ₹0.55 Cr | ₹8.82 Cr | ₹15 Cr |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹21 Cr | ₹23 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr |
Other current_assets | ₹8.44 Cr | ₹7.76 Cr | ₹12 Cr | ₹28 Cr | ₹24 Cr |
Short Term Loans and Advances | ₹194 Cr | ₹156 Cr | ₹138 Cr | ₹214 Cr | ₹189 Cr |
Advances recoverable in cash or in kind | ₹15 Cr | ₹7.47 Cr | ₹11 Cr | ₹23 Cr | ₹30 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹180 Cr | ₹149 Cr | ₹128 Cr | ₹191 Cr | ₹159 Cr |
Total Current Assets | ₹1,694 Cr | ₹1,588 Cr | ₹1,645 Cr | ₹1,377 Cr | ₹1,686 Cr |
Net Current Assets (Including Current Investments) | ₹986 Cr | ₹949 Cr | ₹1,093 Cr | ₹872 Cr | ₹1,120 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,163 Cr | ₹3,183 Cr | ₹3,314 Cr | ₹3,112 Cr | ₹3,142 Cr |
Contingent Liabilities | ₹32 Cr | ₹151 Cr | ₹145 Cr | ₹152 Cr | ₹182 Cr |
Total Debt | ₹219 Cr | ₹297 Cr | ₹330 Cr | ₹101 Cr | ₹184 Cr |
Book Value | - | 344.18 | 370.39 | 362.05 | 358.85 |
Adjusted Book Value | 335.11 | 344.18 | 370.39 | 362.05 | 358.85 |
Compare Balance Sheet of peers of UNICHEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
UNICHEM LABORATORIES | ₹3,893.8 Cr | -6% | -19.7% | -5.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
UNICHEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
UNICHEM LABORATORIES | -6% |
-19.7% |
-5.5% |
SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses